MEMelis Erçelik

Melis Erçelik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melis Erçelik has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Patient-Derived Glioblastoma Organoid Model that Preserves Intra- and Intertumoral Heterogeneity

    by Melis Erçelik, Çağla Tekin, Pınar Eser Ocak, Ahmet Bekar, Hasan Kocaeli, Mevlüt Özgür Taşkapılıoğlu, Berrin Tunca

    Glioblastoma (GB) is an aggressive brain tumor characterized by extensive heterogeneity. We aimed to generate patient-derived GB organoids preserving histological features and to establish a biobank for future studies. Materials and Methods: Tumor tissues from GB patients were dissected into 0.5–1 mm fragments and cultured for 14 days in organoid medium under orbital shaking. Immunohistochemical analysis was performed to assess GFAP, OLIG2, IDH-1, p53, ATRX, and Ki67 expression before and after organoid formation. Results: All tumor samples formed spherical organoids within 14 days. Histological analysis showed preservation of GB-specific morphological features, including nuclear atypia and pleomorphism. GFAP, OLIG2, and ATRX expression patterns were concordant between parental tumors and organoids in cases. IDH-1 expression was consistent in three patients. Ki67 and p53 expression levels showed similar patterns between organoids and corresponding tumors. Conclusion: Patient-derived GB organoids retain key histopathological features and may serve as a platform for GB modeling.

  • Open Access

    The MALAT1-EZH2 axis regulates PRC2 activity and promotes the mesenchymal phenotype in pediatric atypical teratoid/rhabdoid tumors

    by Melisa Gurbuz, Cagla Tekin, Melis Ercelik, Sevin Avsar Koc, Feray Kockar, Pınar Eser, Mevlut Ozgur Taskapilioglu, Gulcin Tezcan, Burcu Erbaykent, Ahmet Bekar, et al.

    Background: Atypical teratoid/rhabdoid tumors (AT/RT) are aggressive pediatric CNS malignancies characterized by SMARCB1 loss, which leads to the dysregulated expression of Enhancer of Zeste Homolog 2 (EZH2), a key catalytic component of the Polycomb Repressive Complex 2 (PRC2). This dysregulation results in aberrant trimethylation of histone H3 at lysine 27 (H3K27me3), driving tumor progression. While EZH2 inhibitors like tazemetostat are in clinical use, their efficacy remains limited, necessitating a deeper understanding of PRC2 regulation. We investigated the role of long non-coding RNAs (lncRNAs) in modulating the EZH2-PRC2 axis in AT/RT. Methods: Expression levels of lncRNAs (MALAT1, ANRIL, KCNQ1OT1) were analyzed via RT-PCR in 10 archival AT/RT patient tissues. RNA immunoprecipitation (RIP) was performed to identify direct interactions with EZH2. The functional impact of MALAT1 inhibition on H3K27me3 levels, mesenchymal markers (CDH2, TWIST, ZEB1), and tumorigenic behaviors (migration, invasion, sphere formation) was evaluated in vitro. Results: MALAT1, ANRIL, and KCNQ1OT1 were significantly overexpressed in AT/RT tissues ( p < 0.05). RIP assays revealed that only MALAT1 directly interacts with EZH2 in DAOY and primary AT/RT cells. MALAT1 knockdown significantly reduced H3K27me3 levels ( p < 0.05) and markedly impaired cell migration, invasion, and sphere-forming capacity. These phenotypic changes were associated with the downregulation of key mesenchymal markers (CDH2, TWIST, ZEB1). Conclusions: Our findings identify MALAT1 as a critical epigenetic regulator in AT/RT that interacts with EZH2 to maintain the PRC2-mediated repressive landscape. Targeting the MALAT1-EZH2 axis provides a novel translational perspective to enhance the efficacy of epigenetic therapies in AT/RT.


  • Open Access

    Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation

    by Sena Ferah, Mine Çamlibel, Melis Erçeli̇k, Çağla Teki̇n, Gülçin Tezcan, Melisa Gürbüz, Ahmet Bekar, Hasan Kocaeli̇, Berrin Tunca

    Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation - Turkish Journal of Pharmaceutical Sciences


  • Open Access

    miR-22 and miR-30e Mediated Regulation of the SLC2A3/NLRP3 Axis in Oral Squamous Cell Carcinomas

    by Gülçin Tezcan, Mustafa Aslıer, Özlem Saraydaroğlu, Hakan Coşkun, A. Alper Pampu, Hakkı Caner İnan, İlHan Kaya, Çağla Tekin, Melis Erçelik, Berrin Tunca, et al.

    Objective: This research explores the regulation of SLC2A3 and NLRP3 genes in cancers of the head and neck region, including oral squamous cell carcinoma (OSCC), focusing on their contribution to tumor progression and the regulatory effects of specific miRNAs. Methods: SLC2A3 and NLRP3 gene expressions in HNSC were analyzed using the GEPIA database with TCGA and GTEx data. Protein-protein interactions were predicted via the STRING database, while miRNA-mRNA interactions were examined using miRDB. RT-qPCR was used to analyze gene expression in tissue samples obtained from 50 individuals with OSCC and 6 non-cancerous controls, while miRNA levels were measured using TaqMan™ Advanced miRNA Assays. Statistical analyses included t-tests, ANOVA, and Kaplan-Meier survival analysis. Results: SLC2A3 levels were markedly elevated in HNSC tumor samples relative to non-cancerous tissues (p = 0.01) and showed a progressive increase with advancing tumor stages (p = 0.0059). NLRP3 expression was found to be higher in HNSC (p = 0.01) without any significant association with tumor progression. In OSCC, both SLC2A3 and NLRP3 expressions increased with tumor stage and were strongly correlated (p < 0.0001). Elevated NLRP3 was associated with reduced survival rates (p = 0.0001). miR-22 and miR-30e levels decreased with tumor progression and were linked to poor survival (p

  • Open Access

    Matrix metalloproteinase-7 and matrix metalloproteinase-9 expression is upregulated in congenital lung malformations

    by Ayşe Parlak, Seçil Ak Aksoy, Melis Erçelik, Çağla Tekin, Hülya Öztürk Nazlıoğlu, Berrin Tunca, Arif Nuri Gürpınar

    Background. Congenital lung malformations (CLMs) refer to structural abnormalities of the lungs that occur during fetal development. Matrix metalloproteinases (MMPs) constitute a group of zinc-dependent enzymes, with certain members of this family playing pivotal roles in the remodeling of the lungs both prenatally and postnatally. This study aimed to explore expression levels of MMP-2, MMP-7, and MMP-9 in CLMs which are recognized as pivotal contributors to their clinical pathology. Methods. A total of 41 patients between the ages of 0-17 years that had undergone lung surgery for CLMs between March 2007- July 2023 were analyzed. The demographic features, clinical and pathological findings were recorded. The expression levels of MMP-2, MMP-7 and MMP-9 in patients’ tissues were examined by reverse transcription polymerase chain reaction and compared in CLMs and adjacent normal lung tissues. Results. Among patients with CLMs, 12 patients had congenital pulmonary airway malformations (CPAM, one patient had bilateral lesions), 18 patients had bronchopulmonary sequestration (BPS), 7 patients had congenital lobar overinflation (CLO), and 4 patients had bronchogenic cyst (BC). The higher expression of MMP-7 and MMP-9 in all CLM tissues compared to normal tissue was observed. But, there was a trend in MMP-2 expression in CPAM tissues and MMP-2 showed high expression in the BPS, CLO and BC groups, which was not statistically significant. Upon collective analysis of all groups, it was observed that mRNA expressions of MMP-7 and MMP-9 exhibited greater upregulation in CPAM and BC in comparison to BPS and CLO. Conclusions. Our findings indicate a specific involvement of MMP-7 and MMP-9 in the pathogenesis of CLMs, particularly in CPAM and BC. To the best of our knowledge, this research represents the initial demonstration of MMP expression in CLMs.

  • Frequency and Clinical Impact of Microsatellite Instability in Colorectal Dysplasia Subgroups

    by Seçil Ak Aksoy, Tuncay Yılmazlar, Melis Erçelik, Çağla Tekin, Nesrin Uğraş, Ömer Yerci, Ersin Öztürk, Selim Gürel, Özgen Işık


  • Olea europaea L. Leaf Extract Attenuates Temozolomide-Induced Senescence-Associated Secretion Phenotype in Glioblastoma

    by Melis Erçeli̇k, Berrin Tunca, Seçil Ak Aksoy, Çağla Ak Aksoy, Gülçin Tezcan

    Objectives: The purpose of this study was to investigate the effect of Olea europaea L. leaf extract (OLE) on senescence and senescence-associated secretory phenotype (SASP) caused by temozolomide (TMZ) in glioblastoma (GB).Materials and Methods: A senescence beta-galactosidase assay and a colony formation assay were used to determine the effects of OLE, TMZ, and OLE + TMZ on the cellular senescence and aggressiveness of GB cell lines T98G and U87MG. mRNA expression levels of p53, a senescence factor, interleukin (IL)-6, matrix metalloproteinases (MMP)-9, and nuclear factor kappa B1 (NF-kappa B1) as SASP factors and Bcl-2 and Bax as senolytic markers were assessed using quantitative reverse transcription-real-time polymerase chain reaction. Cells were double-stained with acridine orange and propidium iodide to observe the cell morphology.Results: TMZ increased the senescence rate of GB cells (p<0.001). Besides, OLE + TMZ reduced the proportion of senescent cells (p<0.001) and their capability to form colonies compared to TMZ-only-treated cells. Additionally, OLE + TMZ co-treatment elevated the mRNA expression levels of MMP-9, IL-6, NF-kappa B1, p53, and the Bax/Bcl-2 ratio compared to TMZ-only treatment. Especially in U87MG cells, involvement of OLE in TMZ treatments increased more than six times in the Bax/Bcl-2 ratio compared to TMZ-only, which induced the apoptosis-like morphological features (p<0.0001).Conclusion: Collectively, our findings presented the inhibitory effect of OLE on TMZ-mediated SASP-factor production in GB and, accordingly, its potential contribution to elongate the time of recurrence.


  • Open Access

    High SNAIL Expression Reflects Of Recurrence After Resection Colorectal Cancer Liver Metastasis

    by Ahmet Karamustafaoğlu, Secil Ak Aksoy, Berrin Tunca, Melis Erçeli̇k, Çağla Teki̇n, Nesrin Uğraş, Ömer Yerci̇, Fuat Aksoy, Ekrem Kaya

    Introduction: Metastasectomy is one of the effective treatment methods for liver metastases developing from primary colorectal cancer (CRC). However, recurrence after metastasectomy is the biggest problem in these cancers. The present study aimed to examine the role of Epithelial-Mesenchymal Transition (EMT) in the development of recurrence after metastasectomy in liver metastases from primary CRCs. Materials and Methods: In the study, 85 patients were evaluated. RNA was isolated from archive tumors and normal tissues of the patients. Expression profiles of 7 different EMT markers were examined using qRT-PCR. Results: Metastasis to the liver developed in 24.7% (n=21) of 85 CRC. Recurrence was observed in 42.3% (n=9) of liver metastases after metastasectomy. Statistically significant increases were detected in the expression of EMT markers TWIST and SNAIL in the development of mCC in primary CRC (p